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Abstract
Malarial anaemia is an enormous public health problem in endemic areas and occurs predominantly
in children in the first 3 years of life. Anaemia is due to both a great increase in clearance of
uninfected cells and a failure of an adequate bone marrow response. Odhiambo, Stoute and
colleagues show how the age distribution of malarial anaemia and the haemolysis of red blood cells
may be linked by an age-dependent increase in the capacity of red blood cells to inactivate
complement components absorbed or deposited directly on to the surface of the red blood cell.
In this commentary, we discuss what has been established about the role of complement deposition
on the surface of red blood cells in the pathology of malarial anaemia, how genetic polymorphisms
of the complement control proteins influence the outcome of malaria infection and how the
findings of Odhiambo, Stoute and colleagues and others shed light on the puzzling age distribution
of different syndromes of severe malaria.
Commentary
In the accompanying article, Odhiambo, Stoute and col-
leagues show how the age distribution of malarial anae-
mia and the haemolysis of red blood cells (RBCs) may be
linked by an age-dependent increase in the capacity of
RBCs to inactivate complement components absorbed or
deposited directly on to the surface of the RBC [1]. The
work raises not only a number of important new lines of
research but also challenges malaria researchers to apply
this basic work to develop new ways to prevent and treat
malaria.
Malaria remains an enormous problem in public health
around the world [2]. Over 2 billion people live in
malaria-endemic areas and up to 1 million children die
each year of malaria. Severe falciparum malaria may
present a variety of syndromes, but presents most fre-
quently in childhood with severe malarial anaemia or
coma. The difference in age distributions of children pre-
senting with these syndromes is as striking as it is puz-
zling; the median age of children presenting with severe
malarial anaemia is typically 1 to 3 years old, while the
median age of children presenting with coma is signifi-
cantly and consistently older, typically 3 to 5 years old [3].
Furthermore, there remain major unsolved problems
about the fundamental pathophysiology of all syndromes
of severe malaria. The rapid drop in haemoglobin during
acute infection and the slower decline in chronic infection
appear to be due to increased extravascular haemolysis of
RBCs with a concomitant failure of the bone marrow to
increase red cell production to compensate for these
losses [4].
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The increased clearance of infected cells is readily
explained by the rupture of cells after completion of the
parasite's intra-erythrocytic life cycle and opsonisation
and clearance of intact infected RBCs. Rather less obvious
is why and how uninfected cells are also cleared. It has
been estimated that approximately 10 uninfected cells are
cleared from the circulation for every infected cell and so
the clearance of uninfected cells is of crucial importance
for the development of malarial anaemia [5].
Why are uninfected RBCs cleared in such large numbers?
Certainly the number and activation of splenic and other
macrophages for phagocytosis of red cells is greatly
increased during malarial infection [6-9]. The increased
clearance of uninfected erythrocytes is also due to extrin-
sic and intrinsic changes to the RBCs that enhance their
recognition and phagocytosis.
Uninfected RBCs have a reduced deformability leading to
enhanced clearance in the spleen and a severe reduction in
red cell deformability is also a strong predictor for mortal-
ity measured on admission, both in adults and children
with severe malaria [10,11]. Second, the deposition of
immunoglobulin and complement on uninfected RBCs
may enhance receptor-mediated uptake by macrophages.
The role of immunoglobulin and complement in marking
uninfected RBCs for clearance by phagocytes was first
studied by Facer and colleagues [12,13] in The Gambia in
the 1970s. It soon became clear that the Direct Coombs'
Test (DCT) for immunoglobulins and/or complement
deposited on the surface of RBCs was frequently positive
in children with malaria [12]. The antibodies giving rise to
the positive DCT were not autoimmune but were directed
against malarial antigens [13] (and our unpublished
observations) and may include complexes of immu-
noglobulin G (IgG) with malarial antigens including ring
stage protein 2 [14].
The story of how absorbed immune complexes may con-
tribute to increased clearance of uninfected RBCs lay dor-
mant for 20 years when Waitumbi, Stoute and colleagues
based in Western Kenya began to study how immune
complexes caused haemolysis [15]. Appreciation of this
work requires some knowledge of the control of comple-
ment deposition on the surface of RBCs.
Here, a number of proteins are involved in the control of
complement activation. Complement receptor 1 (CR1 or
CD35), decay accelerating factor (DAF or CD55) and the
membrane inhibitor of reactive lysis (MIRL or CD59) may
enhance binding of C3b in immune complexes (CR1),
enhance inactivation of C3 convertases (CR1 and CD55)
and interfere with the assembly of the terminal compo-
nents of complement that form the membrane attack
complex (CD59) [16]. Immune complexes and CR1 may
then be removed by splenic macrophages and the RBCs
depleted of immune complexes CR1 (CD35) and CD55
and returned to the circulation.
In previous papers, Waitumbi, Stoute and colleagues have
shown that the amount of red cell surface IgG is increased
but red cell surface CR1 and CD55 reduced in children
with severe malaria compared with asymptomatic and
symptomatic controls [15]. The difference in surface IgG
levels appeared to be functionally significant as RBCs
from children with severe anaemia were more susceptible
to phagocytosis in vitro than RBCs from controls. Decline
in CD35 or CR1 expression and increases in immune
complexes bound on uninfected RBCs were associated
with anaemia but these declines in CD35 (CR1) and
CD55 expression were only transiently associated with
malaria infection and levels returned to normal after
infection had been cleared [17]. These data are all consist-
ent with the ability of CD35 and CD55 to inactivate the
formation of C3a and reduction in CD35 and CD55
expression when bound immune complexes are cleared
by phagocytes.
How does this relate to the age-dependent incidence of
malarial anaemia? Population studies in Europe and
Africa showed the CR1 expression was strongly age-
dependent and increases of both CR1 and CD55 were
seen after 4 years of age and low levels of CR1 and CD55
expression were seen in a cases of severe malarial anaemia
compared with slightly older children with cerebral
malaria [18]. Odhimbo, Stoute and their colleagues now
show that haemoglobin is inversely associated with
increased age and percentage C3b-positive uninfected
RBCs are inversely and directly associated with CR1 levels
measured shortly after infection [1]. Therefore, reduction
in these proteins (CR1, CD55 and CD59) may increase
the susceptibility of children to malarial anaemia.
How do these findings help explain the age distribution of
syndromes of severe malaria? If clearance of the immune
complexes absorbed on to the surface of uninfected cells
is reduced in younger children expressing lower levels of
CD35 and CR1, then clearance of these cells would be
increased, leading to more anaemia in these younger age
groups.
Genetic polymorphisms also affect the expression levels,
sequence and domain  structure of CR1 in Africans and
other populations [19,20]. Moreover, CR1 is a ligand for
the variant antigens expressed at the surface of infected
RBCs allowing the formation of rosettes of infected and
uninfected RBCs [21,22]. In Melanesian populations, low
levels of CR1 expression have been associated withBMC Medicine 2008, 6:24 http://www.biomedcentral.com/1741-7015/6/24
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reduced rosette formation and protection from severe
malaria [20].
It is possible therefore, that age-related and genetically
determined reduction of levels of CR1 expressed on RBCs
are associated with an increased susceptibility to anaemia
but protection from other forms of severe malaria and
may provide an example of how innate resistance to one
syndrome of malaria may be at the expense of susceptibil-
ity to other pathophysiological pathways involved in
malaria infection.
These hypotheses should ideally be tested in longitudinal
studies using genetically and phenotypically well-charac-
terised children to ascertain the levels of these age-
dependent, complement regulatory proteins prior to
infection and determine their association with haemo-
globin levels during acute infection and with the inci-
dence of severe disease through childhood. Such studies
can only be done in a few sites in Africa where large pop-
ulations can be followed before and after infection and
presentation to a health facility using a demographic sur-
veillance system.
In assessing the role of these age-related changes to the
complement regulatory proteins in the differential presen-
tation of anaemia and coma, one would also have to con-
sider the recently described findings of increased levels of
erythropoietin (EPO) seen in younger children with anae-
mia [23] and malaria [24] and the increased protective
effect of EPO on survival after coma, particularly in a
younger age group [25]. These alternative explanations for
susceptibility to anaemia in younger age groups on one
hand and increased protection from cerebral malaria or
coma on the other are not mutually exclusive and it is pos-
sible, indeed likely, that many factors underpin such a
well-defined difference in the clinical epidemiology of
these malarial syndromes.
Finally, we would ask where these studies will lead in the
quest for new methods to prevent or treat malarial infec-
tion. The findings of Odhiambo, Stoute and colleagues
presented in the accompanying article in BMC Medicine
provide us with a clearer understanding of the causes of
anaemia in children with malaria. Translating this new
understanding of pathology into fruitful avenues to inves-
tigate prevention and treatment of malaria is perhaps the
greatest challenge of clinico-pathological studies in this
and other disciplines.
List of abbreviations
CR1: complement receptor 1; DAF: decay accelerating fac-
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blood cell.
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